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Abstract
Psoriasis is prone to relapses and requires long-term therapy 
that may induce a range of adverse effects; therefore, an ef-
ficient and early detection of relapses is desirable. In this 
study, photoacoustic imaging and confocal laser scanning 
microscopic (CLSM) methods were investigated for their 
suitability in psoriasis follow-up examinations. Using a high-
resolution photoacoustic system, the vascular structures of 
11 psoriatic patients and 6 healthy volunteers were investi-
gated. No differences were detected with respect to the av-
erage vessel diameter and vasculature per unit volume in the 
tissue of healthy volunteers and non-lesional and lesional 
skin areas of psoriatic patients. By means of CLSM, the diam-
eters of the dermal papillae of 6 volunteers and 6 psoriatic 
patients were determined. The diameters of the dermal pa-
pillae of the healthy volunteers (0.074 ± 0.006 mm) revealed 
no significant difference when compared to non-lesional 
skin areas of psoriatic patients (0.079 ± 0.005 mm). The re-
sults obtained for the lesions in psoriatic patients showed a 
significant difference (Wilcoxon test, p = 0.028) between the 
diameters of the dermal papillae of the lesional skin areas 
(0.114 ± 0.012 mm) and the non-lesional skin areas (0.079 ± 
0.005 mm). Thus, CLSM can be applied for monitoring pso-
riasis follow-up examinations. © 2018 S. Karger AG, Basel
Introduction
With prevalence rates in adults reported to be between 
0.51 and 11.43%, psoriasis is one of the most frequent in-
flammatory skin diseases [1]. In Germany alone, about 
2 million people are affected by this condition. For the af-
fected subjects, psoriasis often entails a considerable stig-
ma as well as restrictions with regard to their quality of life 
and their physical and mental health [2, 3]. The annual 
health care costs are substantial. In a disease-cost study 
conducted in Germany, it was shown that the annual total 
expenditure per patient amounts to approximately EUR 
3,000 and even to approximately EUR 5,000, if the patient 
additionally undergoes systemic therapy [4]. In a clinical 
study, it was demonstrated that the restrictions to the phys-
ical and mental abilities of psoriatic patients are compa-
rable to the physical and mental abilities of patients suffer-
ing from cancer, diabetes, cardiac diseases, hypertonia, ar-
thritis, or depression [5]. The pathogenesis of this disease, 
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involving both genetic and environmental factors. Psoria-
sis is currently considered to be a T-cell mediated inflam-
matory reaction [6, 7]. The activation of T-cells stimulates 
the formation of mediators which, in turn, bring about the 
typical structural vascular and epidermal changes in psori-
atic skin. Previous investigations elucidated the impact of 
the changes in the vascular architecture for the pathogen-
esis of psoriasis. Electron microscopic investigations pre-
dominantly revealed changes in the capillary loops inside 
the dermal papillae which, contrary to the capillary loops 
of healthy skin, are multiply twisted and elongated and lose 
their typical hairpin shape [8, 9].
Beside basic therapy, psoriasis treatment is based on 
3 pillars, namely topical, photo, and systemic therapy. In 
daily clinical practice, biomarkers for standardized psoria-
sis monitoring are not yet available. For the assessment of 
the severity of the disease and the therapeutic success, sev-
eral scoring systems are used. In Europe, primarily the Pso-
riasis Area Severity Index and, for the assessment of the dis-
ease-related quality of life, the Dermatology Life Quality 
Index have become established [10]. Beyond a reduction of 
the skin symptoms and monitoring of the disease progres-
sion, an efficient psoriasis therapy is aimed at minimizing 
the side effects and obtaining a long-term remission [11]. 
Due to the chronically recurring progression, often requir-
ing long-term therapy, adverse drug effects, and high ex-
penses of an immunosuppressive therapy, it would be pref-
erable to know whether only superficial lesions are cured 
by this therapy. If so, sub-clinical changes will remain and 
promote the development of recurrences. An efficient ear-
ly detection of relapses and also the possibility of reducing 
or interrupting the systemic therapy in the case of success-
ful treatment would be of great advantage. 
Using laser scanning microscopy, Archid et al. [12] 
found widened diameters of both capillaries and papillae 
in psoriatic versus healthy skin, and a correlation between 
clinical alleviation and normalization of the skin struc-
ture. Wolberink et al. [13] showed a high agreement be-
tween confocal laser scanning microscopy (CLSM) and 
histological investigations using light microscopy when 
detecting the structural changes as well as a clear correla-
tion between clinical alleviation of psoriasis and the de-
tection of the normalization of the structural changes by 
laser scanning microscopy and light microscopy [13].
Laser scanning microscopy is an already established, 
non-invasive in vivo imaging method which might pro-
vide an option to assess the therapy success and define if 
a therapy must be continued until normalization of the 
structural skin changes is reached. However, examina-
tions by laser scanning microscopy require highly spe-
cialized staff, sophisticated microscopy systems, and are 
rather time consuming. 
Alternatively to laser scanning microscopy, photo-
acoustic imaging could be applied. Photoacoustic imaging 
is an innovative, non-invasive procedure, which has be-
come increasingly popular in recent years. It is based on 
the generation of broadband acoustic transients as a result 
of localized optical absorption of short time laser pulses, 
thus joining the advantages of optical and acoustic meth-
ods. Compared to the purely optical procedures, photo-
acoustic imaging is characterized by an increased penetra-
tion depth, and compared to purely acoustic methods, by 
providing higher contrast between different types of tissue. 
All this indicates that photoacoustic imaging is promising 
for future establishment in clinical use [14, 15]. The added 
diagnostic value of photoacoustics has been documented 
in many publications. In first investigations, for example, 
the application potential of this novel technique in breast 
cancer diagnostics was shown [16, 17]. Preclinical investi-
gations on skin could reveal its possible importance for 
dermatology, specifically for staging of melanoma, for ex-
ample, prior to surgery [18] or for determining the depth 
of thermal burns [19]. Favazza et al. [20, 21] could demon-
strate that photoacoustic imaging is specifically suitable for 
representing the vascularization of the skin.
The present study was aimed to investigate photo-
acoustic imaging and CLSM for their applicability in fol-
low-up examinations of psoriasis.
Material and Methods
Photoacoustic Imaging System “SKINSPECTION” 
For the measurements, the Fraunhofer Institut für Biomed-
izinische Technik IBMT (St. Ingbert, Germany) provided us with 
a system that had been developed in collaboration with the com-
pany Kibero (Kibero GmbH, Saarbrücken, Germany) within the 
European research project “SKINSPECTION.” This system inte-
grates a single-element focused ultrasonic transducer of 35 MHz 
center frequency for detecting of acoustic waves. It consists of an 
acoustic lens (curved active area) with a curvature radius of 5.5 mm 
and an active area of 5 mm in diameter. The bandwidth of the 
transducer was measured to be 100% and the extent of the –6 db 
focal zone was 100 μm in lateral and 2.4 mm in axial direction. For 
digitization of the optical generated ultrasonic signals and control-
ling the linear stages that are required for moving the ultrasonic 
transducer mechanically within a 2-dimensional grid, a single-
channel ultrasonic electronics including a PC has been developed.
A frequency doubled Nd:YAG laser system (FDSS 532-150, 
CryLas GmbH, Germany), generating an optical light pulse of 532 
nm, has been used for the photoacoustic signal generation. The 
pulse energy can be defined by the user up to maximum values of 
37 μJ with a repetition rate of 1 kHz. The pulse length of 1.5 ns en-
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to match the frequency of the used transducer. For targeted light 
delivery, the light is coupled into a custom-made fiber bundle 
whose geometry strongly defines the size and the pattern of the ir-
radiated area on the skin surface. In addition, the system is 
equipped with a PC, a hand-held sensor head accommodating 
both the transducer and the motorized positioning unit, and a tai-
lor-made software for visualizing the acquired data. 
In a standard ultrasonic procedure, an acoustic wave is trans-
mitted into the target tissue and the amplitude of reflected signal 
portion is measured. However, in the photoacoustic imaging 
mode, the source of the acoustic waves is the tissue itself. Photo-
acoustic signals are generated based on the thermoelastic effect 
describing the absorption of pulsed electromagnetic radiation on 
tissue structures with high optical absorption coefficients and the 
transformation into heat and pressure [22–24]. If this effect is sub-
ject to thermal and acoustic confinement, the thermal increase 
leads to a volume expansion of the tissue. The resulting local pres-
sure propagates as acoustic waves, which can be detected by ap-
propriate sensors and converted into an electrical signal [25]. The 
penetration depth of the light into the tissue and the contrast of 
photoacoustic imaging are predominantly influenced by the opti-
cal properties of the tissue to be investigated and the wavelength 
of the optical light pulse selected for imaging. The absorption coef-
ficient of melanin, oxy-(HbO2) and deoxyhemoglobin (HHb) de-
creases with increasing wavelength in the near infrared spectral 
region, whereas the absorption of water and fat is enhancing [26–
28]. The wavelength range from 600 to 1,100 nm is called the opti-
cal window. In this optical window, structures at increased depths 
can well be investigated as the overall tissue absorption coefficient 
decreases to a minimum and the tissue scattering is reduced in this 
range [24, 27, 29]. In contrast, light in the range around 500 nm is 
already absorbed in the uppermost dermal layers due to the ex-
tremely high absorption of hemoglobin, which on the other hand 
leads to high-amplitude photoacoustic signals of vascular struc-
tures. Thus, laser sources emitting in this spectral region are par-
ticularly suited to represent blood vessels near the surface.
Volunteers
The investigations were performed with the approval of the 
Ethics Committee of the Charité – Universitätsmedizin Berlin. 
The reference group consisted of 6 healthy volunteers (3 men and 
3 women, mean age 36.2 years), who were clinically healthy at the 
time of the investigations and whose medical history did not show 
any chronic skin disease. All volunteers of the reference group ex-
hibited skin types I–III according to the Fitzpatrick classification 
[30]. For the comparative study, 11 patients (4 women, 7 men; 
mean age 49.1 years) with known psoriasis vulgaris and an acute 
relapse were recruited. All volunteers of the psoriasis group exhib-
ited skin types I–III according to the Fitzpatrick classification [30].
Study Protocol and Study Design
The first part of the study was aimed at determining the accuracy 
and reproducibility of the photoacoustic measurements. The related 
investigations were initially performed on healthy volunteers. There-
fore, a skin area was marked at the volunteer’s forearm and subse-
quently the sensor of the photoacoustic system was positioned on the 
marked area, the measurement was performed and the sensor was 
lifted. This procedure was carried out 6 times on the same skin area in 
order to determine the variation of the measurements. Furthermore, 
a total of six different skin areas on the forearm were measured. In the 
second part of the study, the measurements were performed on pso-
riasis patients. In this case, at least 2 but not more than 3 lesional skin 
areas plus one adjacent non-lesional skin area were investigated.
The photoacoustic measurements were performed on standard-
ized conditions after the subject to be tested had rested in horizontal 
position for at least 5 min at a room temperature between 20 and 
24  ° C. For the measurements, a small amount of ultrasonic gel no 
larger than a thumbnail was applied onto the area to be investigated. 
By slightly spreading the ultrasonic gel, the layer between the skin 
surface and the sensor should become as even as possible. With the 
sensor a skin surface of maximally 9.6 × 9.6 mm in size could be 
scanned with a step-size of 50 μm in x- and y-direction. The focused 
ultrasonic transducer and the resulting limited axial focusing area 
require the best possible parallel alignment of the sensor and the skin 
surface. During the measurement, which lasted 90 s, both the vol-
unteer and the investigator should take care to minimize motion 
artefacts as such artefacts decisively influence the image quality. 
Data Evaluation
The acquired acoustic signals were band pass filtered according 
to the spectral range of the transducer used in the system which min-
imizes the noise level. Data visualization was carried out based on the 
filtered data with a tailor-made software providing 2D sectional im-
ages (B-Scan) and projection images (C-Scan). The maximum am-
plitude projection corresponds to a tissue slice located at a defined 
depth parallel to the skin surface. In order to guarantee parallelism, 
an algorithm has been developed which detects the skin surface at 
each transducer position of the scanned area. Images at different 
depth with different slice thickness can be automatically computed. 
For enhancement of the signals from the vasculature with re-
spect to the background, a vessel enhancement filter, such as de-
scribed by Frangi et al. [31], was used. Basically, the algorithm 
identifies cylinder-like structures by analyzing the local gradient 
and the Hessian matrix in any pixel of the image. The introduction 
of a scaling parameter allows to search for cylindrical structures of 
different radii. In our approach, the scaling parameter is varied and 
the results after filtering with different scales are compared. The 
scale, which maximizes the output, can then be associated to the 
local radius of the vessel. For the quantitative evaluation, the aver-
age vessel diameter in millimeters and the SD were determined. 
Furthermore, for assessment of the vasculature ratio in the in-
vestigated region, the percentage of pixels corresponding to ves-
sels, which correlates to the percentage of vasculature per unit vol-
ume were determined. 
Statistical Evaluation
From the 6 volunteers of the healthy reference group, the arith-
metic and the SD of the retrieved parameters were calculated (in-
ter-patient variability). From the measurements of the 6 different 
skin areas of every volunteer of the reference group, the overall 
mean value, the SD, and the median value were determined (intra-
patient variability). 
From the group of the 11 psoriatic patients, the arithmetic 
mean, the SD, and the median value were calculated for the 2 or 
maximally 3 investigated lesional and the respective adjacent non-
lesional skin areas. The skin areas of the healthy reference group 
and the non-lesional skin areas of the psoriatic patients were com-
pared using the Mann-Whitney U test, whereas the Wilcoxon test 
was applied for comparing the lesional and the non-lesional skin 
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Confocal Laser Scanning Microscope
The investigations were performed using a VivaScope 1,500 
Multilaser (Lucid Inc., Rochester, NY, USA). This CLSM consists 
of a mobile cart accommodating a laser unit that is mounted to a 
swivel arm. For macroscopic investigations, a camera (VivaCam) is 
attached to the system. The related VivaScan software enables pa-
tient data managing and filing. With the appropriate functions, 
skin areas can be scanned along the x–y axis (VivaBlock) and along 
the z-axis (VivaStack ). Using the VivaBlockV function, a skin lay-
er of maximally 8 × 8 mm in size can be scanned in one plane. The 
resulting single images are 500 × 500 μm in size. The VivaStack 
function is to be understood as an optical punch biopsy. In a spe-
cific skin area, different skin depths can be investigated along the 
z-axis via the software. The technical principle of CLSM is based on 
a laser as spot light source that is focused through a connected lens 
onto a specific spot in the tissue. The light reflected from the skin 
structures is led through a pinhole aperture and recorded by a de-
tector. The spot light source, the tissue to be investigated, and the 
aperture of the pinhole are arranged confocally to each other so that 
only the light reflected within the tissue area in the confocal plane 
is imaged on the detector. The light reflected beyond this place is 
filtered out, thus providing a high resolution. The pinhole aperture 
can therefore represent only a specific image spot. In order to ac-
quire the entire tissue, the plane to be investigated must be scanned. 
The individual spots of the plane under investigation are composed 
to form a complete image [32, 33]. The imaging procedure is based 
on reflectance and scattering of the individual cutaneous layers and 
cell structures, and depends on the refractive indices. The greater 
the difference between the refractive indices of the individual skin 
structures, the stronger the imaging contrast. Melanin and keratin, 
for example, exhibit a high refractive index and generate a bright 
contrast [34, 35]. Due to the high lateral resolution of CLSM rang-
ing from 0.5 to 1 μm, structures can be represented even in the cel-
lular region, although the penetration depth of CLSM into the skin 
is limited to between 250 and 300 μm. The axial resolution, that is, 
the layer thickness, amounts to approximately 3–5 μm [36, 37].
Volunteers
The investigations were performed with the approval of the 
Ethics Committee of the Charité – Universitätsmedizin Berlin. 
The reference group consisted of 6 healthy volunteers (5 women, 
1 man) who were clinically healthy at the time of the investigations 
and whose medical history did not show any chronic skin disease. 
The mean age of the healthy volunteers was 37.7 years. Five volun-
teers of the reference group exhibited skin types I–III according to 
the Fitzpatrick classification [30]; one volunteer exhibited skin 
type V. The group of psoriatic patients consisted of 6 volunteers 
(3 women, 3 men; mean age 47.8 years). For the measurements, 
patient whose plaques were already healing and showed almost no 
desquamation were recruited. Five patients in the psoriasis group 
exhibited skin types I–III according to the Fitzpatrick classification 
[30] and one volunteer exhibited skin type V.
Study Protocol and Study Design
Using a CLSM, the measurements were performed on stan-
dardized conditions after the subject to be tested had rested in hor-
izontal position for at least 5 min at a room temperature between 
20 and 24  ° C. 
Prior to starting the investigations, the filter on the VivaScope 
was adjusted to reflectance and a laser wavelength of 785 nm was 
selected. For every volunteer, a suitable skin area on the forearm 
was chosen. Subsequently, 5 different regions in this skin area were 
captured on the stratum corneum plane by scanning along the x–y 
axis and via the VivaStack® function along the z-axis down to the 
stratum papillare. For the psoriatic patients, one non-affected and 
one diseased skin area, both without serious desquamation on the 
forearm, were investigated. Here too, 5 different regions were 
scanned along the z-axis down to the stratum papillare plane. 
Data Evaluation
By scanning along the x–y axis, 5 single images from the se-
lected skin area of every volunteer were captured. All papillae in a 
500 × 500 μm section of the respective images at the level of the 
stratum papillare were counted and their maximum diameters 
were measured. For this purpose, a rim consisting of basal cells and 
melanocytes was included. The diameters were measured using the 
specifically developed VivaScan® software.
Statistical Evaluation
At first, the arithmetic mean and the SD of all papillary diam-
eters in the 5 different sectional views of 500 × 500 μm per skin area 
of every healthy volunteer and every psoriatic patient were ac-
quired. For comparing the papillary diameters of the healthy vol-
unteers and the non-lesional skin areas of the psoriatic patients, 
the Mann-Whitney U test was applied. The Wilcoxon test was used 
for comparing the papillary diameters of the lesional and the non-
lesional skin areas of the psoriatic patients. 
Results
Photoacoustic Imaging System “SKINSPECTION”
The first part of the investigations was aimed at testing 
the accuracy and reproducibility of the photoacoustic 
measurements. Therefore, repeated measurements were 
performed on one marked skin area of 6 healthy volun-
teers, with the sensor being repositioned before each 
measurement. The results for the mean vascular diameter 
in millimeters and the percentage volume occupied by the 
vessels from 6 repeated measurements are represented as 
arithmetic mean and SD in Table 1. Despite the small 
Table 1. Mean value and SD from 6 repeated measurements of a 
marked skin area in healthy volunteers
Volunteer Average vessel diameter, 
mm, mean ± SD
Vasculature per unit 
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number of volunteers, the data indicate a high reproduc-
ibility of the measurements. 
Using the photoacoustic imaging system, subcutane-
ous vascular networks could be visualized. A mere visual 
evaluation did not show a significant difference between 
the healthy volunteers and the lesional and non-lesional 
skin areas of the psoriatic patients (Fig. 1).
The quantitative comparison between the average vessel 
diameters in the skin of the healthy volunteers (mean value 
0.229 ± 0.023 mm; median value 0.234 mm) and non-le-
sional skin areas of the psoriatic patients (mean value 
0.225 ± 0.042 mm; median value 0.242 mm) showed no sig-
nificant difference. The percentage of vasculature per unit 
volume in the healthy volunteers (mean value 22.395 ± 
1.501%; median value 23.213%) compared to that in the 
non-lesional areas of the psoriatic patients (mean value 
24.318 ± 4.796%; median value 23.078%) did not disclose a 
significant difference either. Comparing the average vessel 
diameters of lesional (mean value 0.201 ± 0.049 mm; me-
dian value 0.178 mm) and non-lesional (mean value 0.225 ± 
0.042 mm; median value 0.242 mm) skin areas of psoriatic 
patients, no significant difference was found. Neither was a 
significant difference observed when comparing the mea-
sured percentage of vasculature per unit volume in the le-
sional (mean value 22.754 ± 7.201%; median value 24.986%) 
and the non-lesional (mean value 24.318 ± 4.796%; median 
value 23.078%) skin areas of the psoriatic patients.
In summary, it can be stated that neither between the 
healthy volunteers and the psoriatic patients nor between 
the lesional and the non-lesional skin areas of the psori-
atic patients, significant differences were detectable in 
terms of the average vessel diameter and the percentage 
of vasculature per unit volume of the vessels of the sub-
cutaneous plexus.
Confocal Laser Scanning Microscopy
Laser scanning microscopy was applied to determine 
the diameters of the dermal papillae, which were visible 
in the skin of the healthy volunteers as dark areas that are 
surrounded by a light ring consisting of basal cells and 
melanocytes (Fig.  2a). Based on a purely visual assess-
ment, the dermal papillae in the lesional areas of the pso-
riatic patients appeared to be clearly expanded and the 
capillary loops inside the papillae showed an expanded 
vascular volume, often with visible blood flow. All in all, 
the capillaries seemed to be twisted. This could be recog-
nized by sectioning the vessels several times (Fig. 2c, ar-
rows). The non-lesional areas of the psoriatic patients did 
not disclose a significant expansion of the dermal papillae 
(Fig. 2b).
The maximum external diameters of all clearly recog-
nizable dermal papillae in the skin of the healthy volun-
teers and in the lesional and non-lesional skin areas of the 
psoriatic patients were measured. 
The overall mean value of all papillary diameters in the 
skin of the healthy volunteers was 0.074 ± 0.006 mm. In 
the non-lesional skin areas of the psoriatic patients, the 
overall mean value of the papillary diameters amounted 
to 0.079 ± 0.005 mm; in the lesional skin areas, it was 
0.114 ± 0.012 mm. 
No significant difference was detected in the papillary 
diameters in the skin of the healthy volunteers (median 
value 0.072 mm) compared to those of the non-lesional 
skin areas of psoriatic patients (median value 0.079 mm).
The results of the measurements on psoriatic patients 
yielded a significant difference (p = 0.028) between the 
dermal papillary diameters in the non-lesional skin areas 
(median value 0.079 mm) compared to those in the le-
sional skin areas (median value 0.116 mm).
a b c
Fig. 1. a–c Each showing a 9.6 × 9.6 mm skin area of a healthy volunteer (a), non-lesional skin area of a psori-
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Discussion
The progress and therapy of psoriasis ought to be ef-
ficiently monitored as this disease is particularly prone to 
relapses, and its treatment is frequently accompanied by 
undesired side effects. Optimal psoriasis monitoring 
should facilitate an individualized therapy including 
modulation of a therapy in progress or starting relapse 
prevention, if required. 
The present study was aimed at investigating photo-
acoustic imaging and CLSM methods for their applicabil-
ity in monitoring psoriasis.
Previous investigations had already demonstrated 
the importance of vascular changes for the pathogenesis 
and the progress of psoriasis [9]. It is not precisely 
known if these vascular changes are related only to the 
loop structure or to the whole volume of the capillaries. 
Persistent capillary changes are supposed to promote re-
lapses in spite of superficial healing of the skin lesion 
[38, 39]. In this study, the average vessel diameter and 
the percentage vasculature per unit volume was repre-
sented in a skin area of maximally 9.6 × 9.6 mm using a 
photoacoustic system. Investigations have demonstrat-
ed that such systems lend themselves especially for rep-
resenting cutaneous vessels in vivo [20, 21]. In our study, 
we found that the vascular network represented with the 
photoacoustic imaging system applied exhibited no 
pathological changes. The differences in the measuring 
signals detected in the healthy and the pathological skin 
were statistically insignificant. This was not expected as 
the measuring methods, performed on healthy volun-
teers at the beginning of the investigations, had proven 
to be highly reproducible.
The fact that both the average vessel diameter and the 
percentage of vasculature per unit volume were similar in 
the healthy and pathological skin of the patients leads to 
the conclusion that the pathological changes in the vascu-
lar structure do not manifest themselves in the total vol-
ume investigated but only on the capillary loops directly 
underneath the skin. The resolution capacity of the photo-
acoustic system is insufficient to image these small subcu-
taneous structures. Therefore, even larger changes in this 
small volume are not detectable. Aguirre et al. [40] could 
demonstrate the effect of psoriasis on dermal microvascu-
lature by using raster scan photoacoustic mesoscopy in an 
ultra-broadband mode (10–180 MHz), which achieves a 
higher level of detail and resolution-to-depth ratio. 
In previous studies, capillary changes in psoriatic skin 
have been demonstrated [8, 9]. The widening of the capil-
laries is frequently accompanied by dilated papillae. How-
ever, the correlation between the papillary diameter and 
the progress of psoriasis has rarely been investigated. The 
investigations carried out by laser scanning microscopy in 
the second part of this study impressively showed signifi-
cant differences in the papillary diameters of lesional (0.114 
± 0.012 mm) versus non-lesional (0.079 ± 0.005 mm) skin 
areas of psoriatic patients. No difference could be found 
between the papillary diameters in the skin of healthy pa-
tients compared to those in non-lesional skin of psoriatic 
patients. Ardigo et al. [41] investigated the applicability of 
confocal light microscopy for therapeutic psoriasis moni-
toring. In this case, dermal papillae of > 100 µm in diameter 
were defined as being widened. A significant reduction of 
the papillary diameters and the widened vessels within the 
papillae subsequent of 8 weeks of therapy with a tumor ne-
crosis factor-α antibody could be shown. In a study, Archid 
100 µm 100 µm 100 µma b c
Fig. 2. a–c Confocal image of dermal papillare in a healthy volunteer (a), a non-lesional area (b), and a lesional 
skin area of a patient affected by psoriasis vulgaris (arrows: elongated, widened and tortuous capillary loops 
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et al. [12] could also demonstrate a distinct widening of the 
papillary diameters (146.46 ± 28.52 μm) in psoriatic skin 
as well as a significant difference to healthy skin (69.48 ± 
17.16 μm). The papillary diameters in psoriatic skin mea-
sured in that study contradicts our results (0.114 ± 0.012 
mm). This discrepancy could be due to the fact that our 
psoriatic were examined during therapy, whereas Archid 
et al. [42] included only patients into their study who had 
not received any anti-psoriatic therapy in the 2 months 
prior to the study. Interestingly, a further investigation 
conducted by Archid et al. [42] on 11 patients showed that, 
in terms of the percentage reduction of the Psoriasis Area 
Severity Index value, a clinical improvement under Goeck-
erman therapy correlated with a normalization of the pap-
illary structure rather than of the capillaries [42]. Another 
study performed by Ardigo et al. [43] showed separate ten-
dencies in the microscopic changes during the administra-
tion of 2 local therapeutics of different effects. These results 
suggest that laser scanning microscopy could be a suitable 
method for psoriasis monitoring. However, there are also 
considerable restrictions for the application of laser scan-
ning microscopy to psoriatic skin investigations. In anoth-
er study, Ardigo et al. [44] could find a strong correlation 
between CLSM and histology in terms of psoriasis assess-
ment. However, a high degree of hyperkeratosis, parakera-
tosis, acanthosis, and spongiosis can lead to a reduced pen-
etration of light into the tissue, thus impeding the assess-
ment of the dermal papillae and the dermo-epidermal 
junction [44]. Here as well, a distinct widening of the pap-
illary diameters (median value 151 μm) compared to the 
control group (median value < 80 μm) in psoriatic skin 
could be determined. In this case, the papillary diameters 
in psoriatic skin, which conflicted with our results (0.114 ± 
0.012 mm) can also be explained by the fact that Ardigo et 
al. [44] only included psoriatic patients into their study, 
who had not received any systemic or topical therapy with-
in the previous 4 months. The assessment of the dermal 
papillae can also be impeded by low melanin concentra-
tions and, consequently, low contrast CLSM images [34, 
45]. Lagarrigue et al. [46] could show in a study on 111 
volunteers that the papillary contrast as measured in the 
dermo-epithelial junction seems to be a reliable marker for 
skin pigmentation and clearly correlates with the skin 
types according to the Fitzpatrick classification [30]. Con-
sequently, an assessment of the dermal papillae in patients 
of skin types I and II according to the Fitzpatrick classifica-
tion [30] is impeded [45, 46]. In addition, a lacking papil-
lary ring in psoriatic skin may limit the assessment of the 
dermal papillae. In their study involving 36 psoriatic pa-
tients, Ardigo et al. [44] could show that in 86% of the pso-
riatic lesions, the dermal papillae were not surrounded by 
a bright papillary ring consisting of basal keratinocytes and 
melanocytes. This ring was only recognizable as a shadowy 
structure [44]. This may be due to an inhibition of the mel-
anin synthesis or the increasing apoptosis of melanocytes, 
which is triggered by the tumor necrosis factor-α [44, 47]. 
Further investigations are required to elucidate these 
changes in psoriatic skin. 
In summary, the investigations have shown that the 
pathological changes in the vascular structures of psoriatic 
patients manifest themselves predominantly in the capil-
lary loops but not in the deeper blood vessels. As the reso-
lution of the photoacoustic system applied was not high 
enough to represent the changes in the structure of the cap-
illary loops, the performed photoacoustic measurements 
are unsuitable for the described investigations. To make it 
suitable, the frequency of the ultrasonic transducer would 
have to be increased, so that a higher resolution can be 
achieved [40]. Consequently, laser scanning microscopy 
remains the method of choice for the detection of patho-
logical changes in psoriatic skin. Laser scanning micros-
copy is already established in dermatology, and the papil-
lary diameter is a parameter relatively easy to measure. The 
determination of the papillary diameter seems to be suit-
able for monitoring the clinical course in psoriasis. 
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